Pegylated interferon lambda

A new drug quashes all coronavirus variants. But regulatory hurdles and a lack of funding make it unlikely to reach the U.S. market anytime soon. So starts the NYT article. Have we learned nothing? As for the drug itself, the news is good: …a new class of variant-proof treatments could help…#rainwaterfoundation #republicans
Source: Reuters: Health - Category: Consumer Health News Source Type: news